Same Indication

Pembrolizumab vs Ramipril

Pembrolizumab vs Ramipril: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Ramipril.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Ramipril: Prodrug converted to ramiprilat; ACE inhibitor.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Ramipril — 13-17 hours.

Chemical Properties

Molecular Formula: Ramipril — C23H32N2O5.

Molecular Weight: Ramipril — 416.5120 g/mol.

Type: Pembrolizumab — Antibody; Ramipril — Small molecule.